Drug Trial Radar · NCT07165951
Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Last checked: Nov 20, 2026Latest source record: May 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
566
Planned (sponsor's estimate)
Start
Dec 2, 2025
Primary completion
May 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study adopts a randomized, open label, placebo-controlled, multicenter trial design. OS was the primary endpoint, and eligible subjects were randomly divided into 1:1 groups and received TQB2868 injection and anlotinib hydrochloride capsules combined with chemotherapy, compared to placebo combined with chemotherapy.
Conditions
- Metastatic Pancreatic Ductal Adenocarcinoma
Interventions
TQB2868 InjectionDrug
TQB2868 injection: PD-L1 and Transforming Growth Factor-beta (TGF - β) dual antibody
Anlotinib Hydrochloride CapsulesDrug
Anlotinib Hydrochloride Capsules
Gemcitabine Hydrochloride InjectionDrug
Gemcitabine Hydrochloride Injection
Paclitaxel for InjectionDrug
Paclitaxel for Injection
TQB2868 PlaceboDrug
TQB2868 Placebo without drug substance
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall SurvivalTime frame: The duration is approximately 2 years
Locations
71 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of USTC Anhui Provincial Hospital
Hefei, Anhui, China · Not yet recruiting
Anhui Provincial Cancer Hospital
Hefei, Anhui, China · Not yet recruiting
Peking University First Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
Beijing Friendship Hospital,Capital Medical University
Beijing, Beijing Municipality, China · Not yet recruiting
The Fifth Medical Center of Chinese People's Liberation Army General Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
Beijing Daxing District People'S Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China · Not yet recruiting
Mengchao Hepatobiliary Hospital OF Fujian Medical University
Fuzhou, Fujian, China · Not yet recruiting
The Firstaffiliated Hospital of Xiamen University
Xiamen, Fujian, China · Not yet recruiting
Zhongshan Hospital Xiamen University
Xiamen, Fujian, China · Not yet recruiting
Gansu Provincial Hospital
Lanzhou, Gansu, China · Not yet recruiting
The First Hospital of Lanzhou University
Lanzhou, Gansu, China · Not yet recruiting
Lanzhou University Second Hospital
Lanzhou, Gansu, China · Not yet recruiting
Sun Yat-Sen University
Guangzhou, Guangdong, China · Not yet recruiting
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China · Not yet recruiting
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China · Not yet recruiting
Longhua District Central Hospital
Shenzhen, Guangdong, China · Not yet recruiting
Guangxi Cancer Institute
Nanning, Guangxi, China · Not yet recruiting
Guizhou Medical University Affiliated Cancer Hospital Co., LTD
Guiyang, Guizhou, China · Not yet recruiting
Affiliated Hospital of Zunyi Medical Universityl
Zunyi, Guizhou, China · Not yet recruiting
Hainan general hospital
Haikou, Hainan, China · Not yet recruiting
Cancer Hospital Chinese Academy pf Medical Sciences
Langfang, Hebei, China · Not yet recruiting
Tangshan peopel's Hospital
Tangshan, Hebei, China · Not yet recruiting
Daqing Oilfield General Hospital
Daqing, Heilongjiang, China · Not yet recruiting
Harbin Medical University Cancer Hospital
Haerbin, Heilongjiang, China · Not yet recruiting
The First Affiliated Hospital of Henan University of Science & Technology
Luoyang, Henan, China · Not yet recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Not yet recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Not yet recruiting
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China · Not yet recruiting
Hubei Cancer Hospital
Wuhan, Hubei, China · Not yet recruiting
Xiangyang Central Hospital
Xiangyang, Hubei, China · Not yet recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Not yet recruiting
People's Hospital of Hunan Province
Changsha, Hunan, China · Not yet recruiting
Xiangya Hospital of Central South University
Changsha, Hunan, China · Recruiting
Peking University Cancer Hospital Inner Mongolia Hospital
Hohhot, Inner Mongolia, China · Not yet recruiting
Jiangyin People'S Hospital
Jiangyin, Jiangsu, China · Not yet recruiting
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China · Not yet recruiting
Jiangsu Province Hospital
Nanjing, Jiangsu, China · Not yet recruiting
Nantong Tumor Hospital
Nantong, Jiangsu, China · Not yet recruiting
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China · Not yet recruiting
Showing 40 of 71 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.